ADVISORY/Experts Available To Discuss Stem Cell Research Approval in California.

Business Editors

ADVISORY...

--(BUSINESS WIRE)--Sept. 23, 2002

TOPIC: Gov. Gray Davis signed legislation Sunday that will permit stem cell research in California, according to an article by The Associated Press. The bill, written by Sen. Deborah Ortiz, says California will allow embryonic stem cell research and includes the destruction and donation of embryos, the article says. Proponents of stem cell research believe it may lead to a cure for chronic diseases. However, there is the possibility that California's law could be displaced by a federal statute as Congress has yet to act on stem research bills. EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story:

Dr. David Webster, of Webster Consulting Group, Inc., can discuss issues involving the pharmaceutical, biotechnology and medical industries, including stem cell research legislation. 610-758-9500, [e-mail]

Professor Margaret McLean is the director of Biotechnology and Healthcare Ethics at Markkula Center for Applied Ethics Santa Clara University. Holding a doctorate in clinical pathology from the Medical College of Wisconsin and a M.Div. from Luther Seminary, McLean has a second doctoral degree in ethics from the Graduate Theological Union in Berkeley. She is director of the Applied Ethics Center at O'Connor Hospital in San Jose, a member of the Bioethics Committee at O'Connor Hospital, and review committee member on Infant Bioethics and Infant Care at Santa Clara Valley Medical Center. McLean also serves as a consultant to The Tech Museum of Innovation in San Jose. Her professional and research interests include the ethical dimensions of biotechnology especially human reproductive technology, medical and agricultural applications of genetic technology, stem cell technology, neonatology, and end of life decisions. Current projects include participation on the California State Advisory Committee on Human Cloning, a chapter in "The Human Embryonic Stem Cell Debate" to be published by MIT Press and a manuscript on genetic selection. PR: Barry Holtzclaw, director of SCU Media Relations, [e-mail].

Dr. Mary Pat Moyer is the president, CEO, and Chief Science Officer of INCELL Corporation, LLC. Dr. Moyer has more than 30 years of research experience in areas relevant to stem cells, cancer research and therapy, transplantation, and infectious diseases including AIDS and associated diseases. She also has experience in starting technology businesses, entrepreneurism and mentoring. 210-877-0100, [e-mail]

ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue.

ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/ifmd/index.html.